CYP2C19
Genomadix, Mayo Clinic Partner on CYP2C19 Testing for Remote Care For Stroke Patients
The partnership is intended to help expand adoption of the company's rapid PCR system in sites that treat stroke patients, including through telemedicine platforms.
Neurologists treating patients who present with a small stroke or transient ischemic attack are now able to get PGx results to inform their prescription of Plavix within 24 hours.
Researchers at ACC's annual meeting presented data from studies on genotype-guided care for patients who had undergone percutaneous coronary interventions.
The biobank at the Colorado Center for Personalized Medicine has enabled the hospital's EHR system to send gene-drug interaction alerts proactively.
PGx Variants Linked to Poor Plavix Response in UK South Asians Renews Calls for Expanding Testing
Premium
A recent study found 13 percent of British South Asians have CYP2C19 variants that make them poor metabolizers of Plavix and put them at risk for another cardiac event.